At a glance
- Originator Sclavo; Teva Pharmaceutical Industries
- Class Anti-inflammatories; Antirheumatics; Oligopeptides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders
Most Recent Events
- 19 Sep 1995 Discontinued-II for Immunological disorders (Unknown route)